SHL to speak at the Management Forum’s Injectable Drug Delivery seminar
pharmafile | March 11, 2014 | Feature | Sales and Marketing | autoinjectors, mats perrson, shl autoinjector, shl management forum
SHL EVP Mats Persson will be speaking at the upcoming Management Forum Injectable Drug Delivery conference where he will join various other industry experts to discuss the latest knowledge and market trends in injectable drug delivery. Mats will be speaking on the topic of “Latest Self Injection Trends” where he will cover a range of topics from trends of biologics to the benefits of auto injectors.
As the injectable drug delivery industry continues to grow, its landscape also continues to be shaped by various key players that include pharmaceutical companies, prefilled syringe manufacturers and injectable device manufacturers such as SHL. To develop a device that provides efficacy, safety and improves patient compliance requires all of these players to work closely together. Therefore, events like the Management Forum’s Injectable Drug Delivery seminar is crucial as it is the perfect occasion where experts in each area can come together to share their knowledge and bridge outstanding gaps.
“Whether it is drug related or device related, new trends and technologies continue to quickly emerge within the injectable drug delivery industry, making it even more vital for key players to connect and share knowledge on a regular basis. I am very privileged to be given the opportunity to share with the rest of the group at the seminar on the latest trends and future outlooks of self-injection devices such as auto injectors, and I am also looking forward to attending all the other sessions that will take place,” states Mats.
The seminar will take place from March 26th-27th, where Mats Persson will be speaking on Day One at 4:10PM. For more information on other events that SHL will be attending, speaking or exhibiting at, please visit our events section.
About SHL
SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices such as auto injectors and pen injectors. We have over 2,600 staff globally, with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia. SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
Our organization consists of several distinct group companies:
SHL Medical
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies
SHL Healthcare
Develops and manufactures equipment solutions for home, hospital and long term care use
SHL Technologies
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products
SHL Pharma
Provides final assembly, labeling and packaging services of drug delivery devices to the pharmaceutical and biotechnology industries
For additional information visit www.shl-group.com or contact us at info@shl-group.com
SHL Media Contact
Steven R. Kaufman
Marketing Director
+886 32170303
pr@shl-group.com
Related Content
SHL to attend the 2014 PDA Japan: A collaborative approach to developing combination products
Tokyo, Japan – SHL, the world’s largest privately-owned designer, developer and manufacturer of advanced drug …
Auto Injector Innovation: Quality and Compliance
SHL recognizes the importance of this topic and discusses it in more details in an …
